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Native septic arthritis of the glenohumeral joint is an un-
common but potentially devastating condition.1-3) Particu-
larly, end-stage postinfectious glenohumeral arthritis can 
lead to significant pain and disability.4) While there are a 
number of studies focusing on arthroplasty options for the 
sequelae of septic arthritis in the lower extremity5-11) and 
glenohumeral periprosthetic joint infection,12-18) results of 
shoulder arthroplasty for postinfectious glenohumeral ar-
throsis have been less commonly reported. 
There have been a small number of case series on 
the results of shoulder arthroplasty for the sequelae of 
prior septic arthritis.4,19,20) While these studies found low 
reinfection rates, patients sustained high complication and 
reoperation rates with marginally improved functional 
scores. Patients in these studies were mostly treated prior 
to the increased utilization of reverse shoulder arthro-
plasty (RSA),21-23) with only one study of eight patients uti-
lizing an RSA implant for native, end-stage postinfectious 
glenohumeral arthritis.19) Given the clinical difficulty of 
treating this population and the limited treatment options 
available, we aimed to describe our institutional experi-
ence with shoulder arthroplasty in this population. We 
hypothesized that these patients uncommonly experience 
recurrence of infection and will still have mediocre clinical 
outcomes despite utilization of RSA.
Outcomes of Shoulder Arthroplasty Performed for 
Postinfectious Arthritis
Eric Michael Padegimas, MD, Thema A Nicholson, MS, Stephen Silva, BA, Matthew L Ramsey, MD,  
Gerald R Williams, MD, Mark D Lazarus, MD, Surena Namdari, MD
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Background: The purpose of this study was to evaluate the functional outcomes, infection rate, and complications associated 
with shoulder arthroplasty for sequelae of prior septic arthritis.
Methods: This is a retrospective cohort study of 17 patients who underwent shoulder arthroplasty for sequelae of septic arthritis. 
Patients were analyzed for patient-reported outcomes, complications, and reoperations.
Results: The 17 patients in this cohort were an average age of 65.4 ± 12.2 years old, were 58.8% male, and had an average body 
mass index of 27.9 ± 4.1 kg/m2. These patients underwent 14 reverse shoulder arthroplasties (RSAs; 11 after antibiotic spacer 
placement), one anatomic total shoulder arthroplasty after antibiotic spacer placement, and two hemiarthroplasties (both after 
antibiotic spacer placement). Two patients underwent reoperation (dislocated RSAs). There were four complications (23.5%): two 
RSA dislocations, one acromial stress fracture, and one atraumatic rotator cuff tear after hemiarthroplasty. There were no cases 
of postoperative wound complications or infection. At an average of 4.1 ± 1.8 years of follow-up for all 17 of 17 cases, the average 
visual analogue scale pain score was 4.6 ± 2.3, average Single Assessment Numeric Evaluation Score was 59.3 ± 23.7, average 
American Shoulder and Elbow Surgeons Score was 57.6 ± 15.5, and average Simple Shoulder Test was 6.9 ± 2.6 based on “yes” 
responses.
Conclusions: Shoulder arthroplasty after septic arthritis had inconsistent functional outcomes and high complication rates but no 
reinfection.
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METHODS
Following approval by the Institutional Review Board of 
Thomas Jefferson University Hospital, all shoulder ar-
throplasties were identified by querying of an institutional 
shoulder arthroplasty database by International Classifi-
cation of Diseases, ninth revision, Clinical Modification 
(ICD-9-CM). The time period over which this data was 
collected was January 2010 through September 2015. 
The ICD-9-CM codes utilized were 81.80 (anatomic total 
shoulder arthroplasty [aTSA]), 81.81 (partial shoulder 
arthroplasty [hemiarthroplasty]), and 81.88 (RSA). Direct 
chart review was performed on all patients to obtain the 
diagnosis at the time of shoulder arthroplasty. All patients 
who underwent arthroplasty for the sequelae of septic 
arthritis (pain and shoulder dysfunction in the setting of 
prior infectious arthritis) were included. Arthroplasty was 
performed after eradication of the infection either through 
debridement or placement of an antibiotic spacer and a 
course of antibiotics. These patients were not undergoing 
arthroplasty as a treatment for a current or acute infec-
tion, they were undergoing arthroplasty for the sequelae 
of septic arthritis in which the infection had already been 
eradicated. Search was performed of our institutional 
arthroplasty database rather than individuals that were 
coded for a diagnosis of primary septic arthritis for two 
reasons. Firstly, in our institutional database, procedures 
are coded more reliably than diagnoses. Secondly, all ar-
throplasty cases were directly chart reviewed, so all arthro-
plasty cases performed after septic arthritis were known to 
be captured. Patients that underwent revision arthroplasty 
for periprosthetic joint infection were not included. Those 
that underwent arthroplasty after an index antibiotic 
spacer placement for septic arthritis or osteomyelitis of the 
native shoulder were included in this cohort.
Demographic factors such as age, sex, body mass 
index (BMI), and age adjusted Charlson Comorbidity In-
dex were recorded.24) Direct chart review was performed 
on these patients to identify postoperative complications, 
reinfection, reoperation, and range of motion (ROM; at a 
minimum of 1 year after surgery). Additionally, patients 
were contacted at a minimum of 2 years after surgery for 
patient-reported outcomes. The outcomes analyzed were 
visual analogue scale (VAS) pain score, Single Assessment 
Numeric Evaluation (SANE) score,25) American Shoulder 
and Elbow Surgeons (ASES) score,26) and Simple Shoulder 
Test (SST) score.27)
Per protocol at our institution, after a standardized 
skin preparation and surgical exposure, the glenohumeral 
joint was aspirated with a needle prior to arthrotomy. This 
synovial fluid was sent for culture. Once the joint was 
opened, tissue from the anterior capsule, inferior capsule, 
glenoid, and humeral canal, were sent for culture. Each 
culture was placed directly into sterile specimen contain-
ers with previously unused instruments. Specimens were 
held for 2 weeks and sent for both aerobic and anaerobic 
cultures. All procedures were performed at one hospital 
with one microbiology laboratory. All patients received a 
standard regimen of 2 weeks of antibiotics postoperatively 
until the cultures were finalized as negative. The specific 
antibiotic utilized was based on the susceptibilities of the 
organism isolated from previous surgeries. If patients 
had positive cultures, they were kept on antibiotics for at 
least 6 weeks with routine clinical follow-up for signs and 
symptoms of infection by both the surgical team and the 
infectious diseases service at our institution. The decision 
to undergo arthroplasty after placement of an antibiotic 
spacer was based on clinical improvement and normal-
ization of inflammatory laboratory results (erythrocyte 
sedimentation rate and C-reactive protein), and culture 
status from most recent surgery or aspiration. All cases 
were performed by one of five shoulders and elbow fellow-
ship trained surgeons. Fifteen of 17 cases were done by a 
surgeon that has been in practice for over 20 years. One 
case was done by a surgeon in practice for over 10 years 
and the final case was done by a surgeon 5 years into prac-
tice. The specific implant utilized was selected by surgeon’s 
preference. These systems were as follows: Zimmer Biomet 
(Warsaw, IN, USA), DePuy Synthes (Warsaw, IN, USA), 
DJO Global (Vista, CA, USA), and Wright Medical (Mem-
phis, TN, USA). Clinical follow-up after final arthroplasty 
was performed at 2, 6, 12 weeks, 6 months, and 1 year with 
the treating surgeon and up to a year of follow-up with the 
infectious disease team (depending on the treatment pro-
tocol) for monitoring of recurrent infection.
Descriptive statistics (mean, standard deviation, 
minimum, and maximum) were calculated for demo-
graphic factors, postoperative complications, and patient-
reported outcomes. Comparison of proportions by z 
scores was conducted for categorical variables while two 
sample t-test assuming unequal variance was conducted 
for continuous variables. All statistics were calculated with 
Microsoft Excel 2013 (Microsoft, Redmond, WA, USA).
RESULTS
There were 17 patients identified over the 5-year study pe-
riod that underwent shoulder arthroplasty for the sequelae 
of septic arthritis. The average age was 65.4 ± 12.2 years 
(range, 46.2 to 81.3 years). This population was 58.8% 
male. The average BMI was 27.9 ± 4.1 kg/m2 (21.1 to 36.9 
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kg/m2). The average age adjusted Charlson Comorbidity 
Index was 3.5 ± 1.5 (range, 1 to 6). Comparatively, over 
this same time period, there were 2,463 primary shoulder 
arthroplasties and 360 revision shoulder arthroplasties 
performed at the same institution. The 2,463 primary 
patients had a similar preoperative demographic composi-
tion to the study population. They had an average age of 
67.4 ± 11.1 years (p = 0.99), BMI of 30.3 ± 6.7 kg/m2 (p = 
0.97), age-adjusted Charlson Comorbidity Index of 3.7 ± 
1.5 (p = 0.99) and were 47.2% male (p = 0.34). The most 
frequent medical comorbidities in the study population 
were chronic pulmonary disease (4/17, 23.5%), rheu-
matic disease (2/17, 11.8%), cardiovascular disease (1/17, 
5.9%), chronic kidney disease (1/17, 5.9%), and diabetes 
with complications (1/17, 5.9%). Twelve of the 17 patients 
(70.6%) had previous surgery before their infection (Table 
1). Overall, 16 patients had rotator cuff dysfunction at the 
time of arthroplasty (14 irreparable tears, one repairable 
tear, and one greater tuberosity malunion). 
These 17 patients were treated definitively with 14 
Table 1. Previous Surgical History for the Population That Underwent Shoulder Arthroplasty for Infection
Patient Sex Age (yr)
Surgery 
 before 
infection 
Surgery 
for 
infection
Culture Clinical detail
1 Male 61.93 2 4 Staphylococcus epidermidis Two failed open cuff repairs with infection treated with Keflex before 
presentation; four I&Ds
2 Female 74.91 0 2 MSSA Multifocal septic native arthritis, one shoulder I&D 
3 Male 52.68 1 3 Staphylococcus epidermidis One open rotator cuff repair, developed sinus tract 5 
years later, two I&Ds before presentation
4 Female 64.78 5 1 CNS, Propionibacterium acnes Five attempted cuff repairs with symptom recurrence before 
presentation (three scope, two open); one I&D
5 Male 76.85 3 1 Unknown (OSH) Rotator cuff surgery three times before presentation; one I&D
6 Male 52.06 1 2 CNS, Propionibacterium acnes Failed open cuff repair before presentation; two I&Ds 
7 Female 70.83 5 2 CNS Distal clavicle excision with frozen shoulder, four MUA and 
pain pump placed, infected and washed out before presentation
8 Female 79.88 1 2 Staphylococcus lugdunensis, 
Escherichia coli
One scope cuff repair, infected and open I&D before presentation
9 Male 57.78 0 4 MRSA Two injections, septic arthritis with septic emboli to brain and 
endocarditis, three I&Ds before presentation
10 Female 69.25 1 4 CNS, Propionibacterium acnes One cuff repair and capsular release, two I&Ds for infection 
before presentation; one antibiotic spacer before 2-stage
11 Male 47.75 2 1 Staphylococcus epidermidis Two scope labral repairs before presentation; rapidly progressive 
glenohumeral arthrosis
12 Male 80.98 0 4 MRSA, Pseudomonas 
aeruginosa
Nonoperative proximal humerus malunion, three injections; went for 
delayed RSA, but I&D instead
13 Female 77.19 0 2 MSSA One injection for cuff tear arthropathy and plan for RSA, clinically 
infected intraoperatively, spacer placed
14 Female 65.13 2 1 CNS Failed proximal humerus plate and revised to intramedullary nail, 
failed before presentation
15 Male 81.29 0 1 Escherichia coli One injection, worsened and had scope I&D before presentation
16 Male 52.52 2 2 Unknown (OSH) Two failed rotator cuff repairs, purulent drainage with 
I&D before presentation
17 Male 46.19 1 2 Enterobacter agglomerans Failed proximal humerus plate with collapse and septic arthritis 
before presentation
I&D: irrigation and debridement, MSSA: methicillin-sensitive Staphylococcus aureus, CNS: coagulase-negative Staphylococcus aureus, OSH: outside hospital, 
MUA: manipulation under anesthesia, MRSA: methicillin-resistant Staphylococcus aureus, RSA: reverse shoulder arthroplasty.
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RSA (82.4%; 11 after an index resection and placement of 
an antibiotic spacer, three after a single irrigation and de-
bridement), one aTSA (5.9%; after a resection and place-
ment of an antibiotic spacer), and two hemiarthroplasties 
(11.8%; both after a resection and placement of an anti-
biotic spacer). The 14 patients that underwent RSA were 
treated with a reverse implant due to an irreparable and at-
rophied rotator cuff. The one patient that underwent aTSA 
was treated with an anatomic implant in the setting of an 
intact rotator cuff. The two patients treated with a hemi-
arthroplasty had supraspinatus tears that were repaired 
intraoperatively. Utilization of an antibiotic spacer was 
determined by concern for underlying osteomyelitis or in 
the setting of a planned arthroplasty following initial treat-
ment for septic arthritis. The presence of osteomyelitis was 
identified on preoperative imaging or by clinical concern 
intraoperatively. Timing of reimplantation was based on 
clinical improvement and normalization of inflammatory 
laboratory results (erythrocyte sedimentation rate and C 
reactive protein). Thirteen of the 17 patients underwent 
arthroplasty through a deltopectoral approach (76.5%) 
while four of 17 (33.5%) underwent a superior approach 
because of prior surgical incisions. There was substantial 
heterogeneity with regards to rotator cuff integrity, stem 
length, and utilization of cement (Table 2, Figs. 1 and 2).
Regarding outcomes, two of 17 patients (11.7%) 
underwent reoperation at 28 and 64 days postoperatively. 
The first patient sustained an atraumatic RSA disloca-
tion and underwent revision of the glenoid and humeral 
components that were grossly loose intraoperatively. Intra-
A B C
Fig. 1. Preoperative true anteroposterior (AP) (A), AP (B), and axillary (C) radiographs of an 81-year-old female who had multifocal septic native arthritis 
with one previous shoulder irrigation and debridement. 
A B C
Fig. 2. Three-year postoperative true ante-
roposterior (AP) (A), AP (B), and scapular Y 
(C) views of an 81-year-old female who had 
multifocal septic native arthritis with one 
previous shoulder irrigation and debridement 
and underwent a two-staged reverse 
shoulder arthroplasty.
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operative cultures for this case were negative. The second 
patient also sustained an atraumatic RSA dislocation and 
underwent revision to a thicker polyethylene component. 
There were four complications (23.5%): two aforemen-
tioned dislocations, one acromial stress fracture, and one 
atraumatic rotator cuff tear after hemiarthroplasty (patient 
elected not to undergo conversion to RSA). There were no 
cases of postoperative wound complications or reinfection. 
Ten of the 14 patients that underwent RSA (71.4%) had 
ROM data available at a minimum 1-year follow-up (mean, 
2.2 ± 1.7 years). In this cohort, the forward elevation was 
110° ± 30.2° (60° to 150°). Regarding patient-reported 
outcomes, all 17 patients achieved over a 2-year follow-up. 
The average follow-up was 4.1 ± 1.8 years (range, 2 to 8.3 
years) for all 17 cases. Average VAS pain score was 4.6 ± 2.3 
(range, 0 to 8), average SANE score was 59.3 ± 23.7 (range, 
0 to 95), average ASES score was 57.6 ± 15.5 (range, 26.7 
to 83.3), and average SST score was 6.9 ± 2.6 (range, 1 to 
10) “yes” responses.
DISCUSSION
This analysis reviewed the results of shoulder arthroplasty 
in 17 patients with end-stage, postinfectious glenohumeral 
arthritis at mid-term follow-up. RSA was the most com-
mon treatment choice. There were no recurrent infections 
and two patients required further surgery. However, nearly 
one quarter of the population sustained a complication 
(two RSA dislocations, one acromial stress fracture, and 
one rotator cuff tear after hemiarthroplasty) and func-
tional results were mediocre. These complications were 
likely a result of the poor quality of the soft tissue envelope 
and highlight the difficulty of balancing soft tissue tension 
in the setting of multiple previous surgeries as well as the 
local destruction of the antecedent infection and initial de-
bridement. The index infection was treated aggressively in 
this population. Patients with end-stage post-septic arthri-
tis and concern for underlying osteomyelitis were treated 
with multiple debridements and resection arthroplasty 
with placement of an antibiotic spacer. All patients were 
followed by infectious disease specialists perioperatively 
and did not undergo arthroplasty until clinical and sero-
logical resolution of concern for infection. This aggressive 
approach may have contributed to the reinfection rate of 
zero at our institution.
There was only one previous study that included 
RSA in treatment of end-stage postinfectious glenohu-
meral arthritis that was performed by Morris et al.19) and 
evaluated results in eight patients. While seven of eight 
patients were satisfied with their clinical results and there 
were no recurrent infections at an average of 4.4 years of 
follow-up, the complication rate was 37.5%. Mean post-
operative ASES and SANE scores in the analysis by Mor-
ris et al.19) were 78.4 and 59.9, respectively. We reported 
a similar SANE score of 59.3 and a complication rate of 
23.5% to Morris et al.19) Schoch et al.20) performed the larg-
est case series that analyzed a population of 23 shoulders 
treated with either aTSA or hemiarthroplasty for end-stage 
postinfectious glenohumeral arthritis. This study reported 
a 34.8% complication rate, 21.7% reoperation rate, and a 
reinfection rate of 8.7%. Active forward elevation was 112° 
in this series of anatomic arthroplasties which is similar to 
the 110° that we report with use of RSA. A direct compari-
son between studies is difficult to interpret because in the 
study by Schoch et al.,20) seven of the 23 shoulders (30.4%) 
were found to have rotator cuff tears, while the vast major-
ity (94%) of the patients in our study with sequelae of prior 
septic arthritis had rotator cuff dysfunction. Our analysis 
and these prior studies show consistently limited func-
tional results, but a reasonably low reinfection rate with 
only two reinfections across all studies. In knee arthro-
plasty, similar potential for infection eradication has been 
found with two-stage treatment.9) These patients showed 
more improved functional outcomes relative to shoulder 
infection patients. As antibiotic spacer techniques evolve 
further, functional outcomes of second-stage arthroplasty 
in the shoulder may also improve.28)
The results of this study must be considered in the 
context of its limitations. This is a purely retrospective 
study and therefore is subject to all limitations of a ret-
rospective study. The ROM data was particularly limited 
as forward elevation was the only consistently measured 
data point and this was only available in 10 of 17 of this 
population at 1 year. Additionally, patient-reported out-
comes were not available preoperatively and so could not 
be compared to postoperative outcomes scores. Therefore, 
it is difficult to state how much patients improved with 
their final functional scores. Finally, the treatment cohort 
is admittedly heterogeneous with substantial variability in 
terms of prior surgical procedures, rotator cuff integrity, 
bone loss, and other factors that could influence outcome. 
Finally, these patients only represent a small proportion of 
our entire arthroplasty population. Therefore, any mean-
ingful analysis of outcomes between these patients and 
other arthroplasty patients would be limited by different 
population size and composition. Despite this, we believe 
that the heterogeneity apparent in this study reflects the 
true clinical experience with this challenging patient pop-
ulation.
Postinfectious arthritis of the shoulder is an uncom-
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mon problem and treatment remains difficult. Shoulder 
arthroplasty for this indication does not yield robust 
patient-reported outcomes and risks complications. In-
stitutionally, we have found that aggressive treatment of 
the antecedent infection has helped optimize results from 
a reinfection and complication perspective. Any patient 
that initially presented with septic arthritis and a concern 
for osteomyelitis or were known to likely need a future 
arthroplasty were treated with a resection arthroplasty and 
antibiotic spacer early. Importantly, with the presented ap-
proach to this problem, there were no recurrent infections 
at the mid-term follow-up.
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